Anti-D Immunoglobulin

Anti-D immunoglobulin is a purified antibody medicine. It is given to eligible people whose red blood cells do not carry the RhD antigen when there may have been contact with RhD-positive blood, commonly during pregnancy or after birth. The medicine helps remove RhD-positive cells before the immune system makes its own antibodies.

The medicine provides ready-made anti-D antibodies for a limited period. These antibodies attach to RhD-positive red blood cells in the circulation, allowing the body to clear them. It does not change a person's blood group and does not treat anaemia or replace routine pregnancy monitoring.

Anti-D may be offered during pregnancy according to blood-group testing and local clinical guidance. It can also be considered after events that might allow blood to cross between the pregnant person and fetus, and after birth when the baby is RhD-positive or the status requires action. Timing depends on the event and clinical assessment.

There is no simple food, supplement or home treatment that performs the same immune-prevention role. Whether anti-D is needed depends on blood group, the baby's status, the timing and the event. A maternity team can explain the available plan and any testing used to guide it.

Your blood group is checked as part of pregnancy care. If anti-D is advised, the clinician will explain why, how it is administered and what follow-up is needed. Mild soreness at the injection site can occur. Report unexpected or concerning symptoms promptly, especially if you feel unwell after treatment.

Protection is time-limited, so a later exposure may require another dose. Tell the team about previous anti-D treatment, allergies and relevant medical history. The product is screened and prepared for medical use, but individual reactions are possible and observation may be recommended.